C5 and paroxysmal nocturnal hemoglobinuria: For PNH patients with no history of TE who are receiving a C5 inhibitor, adding anticoagulant therapy for primary prophylaxis is not necessary because of the preventive effect of C5 inhibition [10,78,83].